Suboptimal statin adherence and discontinuation in primary and secondary prevention populations

This publication has 29 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study
  European Heart Journal, 1997
• The assessment of refill compliance using pharmacy records: Methods, validity, and applications
  Journal of Clinical Epidemiology, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• Medication compliance and serum lipid changes in the Helsinki Heart Study.
  British Journal of Clinical Pharmacology, 1991
• Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia
  Archives of internal medicine (1960), 1991
• A General Method of Compliance Assessment Using Centralized Pharmacy Records
  Medical Care, 1988